Anivia Medical

Anivia Medical is a medtech company at the forefront of extracorporeal care, focused on critical organ support and neuroprotection. The company has entered the U.S. market with its FDA-cleared Anivia console, designed for short-term cardiopulmonary support and organ transplant perfusion. It is also advancing neuroAnivia, a patented dual-zone temperature control system in clinical development that addresses reperfusion injury in stroke and cardiac arrest by providing targeted brain cooling without systemic hypothermia. Founded by Dr. Henry Lin and Dr. John Gilbert, Anivia’s work reflects a deep integration of clinical expertise and engineering innovation. Supported by 31 global patents and a proven leadership team, Anivia is actively pursuing early U.S. market expansion and clinical validation for its transformative technologies.